
0.6956 Delayed Data As of Dec 07 | ![]() Today’s Change | 0.20 Today|||52-Week Range 5.64 | -78.79% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Atara Biotherapeutics Inc have a median target of 4.80, with a high estimate of 28.00 and a low estimate of 0.50. The median estimate represents a +590.05% increase from the last price of 0.70.
The current consensus among 7 polled investment analysts is to Hold stock in Atara Biotherapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.